» Articles » PMID: 25612939

Ophthalmological Assessment of Cannabis-induced Persisting Perception Disorder: is There a Direct Retinal Effect?

Overview
Journal Doc Ophthalmol
Specialty Ophthalmology
Date 2015 Jan 24
PMID 25612939
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Cannabis is a psychotomimetic agent that induces impairment of sensory perception. We present detailed clinical and electrophysiological data of patients with hallucinogen persisting perception disorder (HPPD) after marijuana consumption.

Methods: A HPPD patient and four heavy cannabis smokers with no visual disturbances (controls) underwent complete ophthalmological examination including psychophysical tests (visual acuity, color vision, visual field, and dark adaptation) and detailed electrophysiological examinations, including extended Ganzfeld ERG, multifocal ERG, and electrooculography (EOG). Furthermore, electrically evoked phosphene thresholds (EPTs) were measured to further evaluate retinal function.

Results: Ophthalmological and most electrophysiological examinations were within normal limits for the HPPD patient and for all control subjects. Interestingly, EOG results of the HPPD patient showed a slightly reduced fast oscillation ratio, diminished standing potentials of the slow oscillations, and a light peak within normal range resulting in higher Arden ratios. The EPTs of the patient were reduced, in particular for pulses with long durations (50 ms) causing visual sensations even at lowest possible currents of the neurostimulator. The control subjects did not reveal such alterations.

Conclusions: Our findings suggest a direct effect of cannabinoids on the retina and retinal pigment epithelium function, which may be involved in disturbances of the visual function experienced after drug consumption. The observations presented here may contribute to the elucidation of the detailed mechanism. Furthermore, EOG and EPT measurements may be useful tools to demonstrate long-term retinal alterations in cannabis-induced HPPD in patients.

Citing Articles

Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.

Bondok M, Nguyen A, Lando L, Wu A Clin Ophthalmol. 2024; 18:3529-3556.

PMID: 39629058 PMC: 11613704. DOI: 10.2147/OPTH.S501494.


Not All Cases of Visual Snows are Benign: Mimics of Visual Snow Syndrome.

Hang C, Leishangthem L, Yan Y Neuropsychiatr Dis Treat. 2021; 17:3293-3300.

PMID: 34785899 PMC: 8591117. DOI: 10.2147/NDT.S338111.


Cannabinoids Modulate Light Signaling in ON-Sustained Retinal Ganglion Cells of the Mouse.

Middleton T, Huang J, Protti D Front Neural Circuits. 2019; 13:37.

PMID: 31164809 PMC: 6536650. DOI: 10.3389/fncir.2019.00037.


Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano M, Lorusso M Brain Sci. 2018; 8(3).

PMID: 29547576 PMC: 5870365. DOI: 10.3390/brainsci8030047.


The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

Orsolini L, Papanti G, de Berardis D, Guirguis A, Corkery J, Schifano F Front Psychiatry. 2017; 8:240.

PMID: 29209235 PMC: 5701998. DOI: 10.3389/fpsyt.2017.00240.


References
1.
Norton J, Corbett J . Visual perceptual abnormalities: hallucinations and illusions. Semin Neurol. 2000; 20(1):111-21. DOI: 10.1055/s-2000-6837. View

2.
Hood D, Bach M, Brigell M, Keating D, Kondo M, Lyons J . ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2011; 124(1):1-13. PMC: 4466109. DOI: 10.1007/s10633-011-9296-8. View

3.
Wimmers S, Coeppicus L, Rosenthal R, Strauss O . Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 2008; 246(5):685-92. DOI: 10.1007/s00417-008-0778-7. View

4.
Marmor M, Brigell M, McCulloch D, Westall C, Bach M . ISCEV standard for clinical electro-oculography (2010 update). Doc Ophthalmol. 2011; 122(1):1-7. DOI: 10.1007/s10633-011-9259-0. View

5.
Krill A, Wieland A, OSTFELD A . The effect of two hallucinogenic agents on human retinal function. Arch Ophthalmol. 1960; 64:724-33. DOI: 10.1001/archopht.1960.01840010726015. View